FDA Inspection
Richard A. Pollak, DPMRichard A. Pollak, DPM – FDA Inspection, Jul 2, 2013
Record Details
This FDA Inspection record concerns Richard A. Pollak, DPM, with an inspection on July 2, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Richard A. Pollak, DPM
- Inspection Date
- July 2, 2013
- Product Type
- Drugs
View Company Profile
ID · 8ac38513-d3c4-4111-8255-382dc52e9cae
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 839797
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Richard A. Pollak, DPM
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 25, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 28, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 20, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 2, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 11, 2013 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Richard A. Pollak, DPM
- FDA Inspection 1122910 - 2020-03-25
- FDA Inspection 1085709 - 2019-03-28
- FDA Inspection 1048238 - 2018-03-20
- FDA Inspection 971441 - 2016-06-02
- FDA Inspection 851584 - 2013-10-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.